NewcelX Ltd. (NCEL) Form 10-K Annual Reports
NewcelX Ltd. (NCEL) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NCEL
CIK: 1783036
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: V8
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Kost Forer Gabbay & Kasierer
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerOhad Uzan
Audit LocationTel Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| EFFECT | 2026-09-22 | — | EFFECT Filing | 9999999995-26-003024 | View SEC Doc Filr Page |
| POS AM | 2026-09-18 | — | POST-EFFECTIVE AMENDMENT NO. 3 TO FORM F-1 | 0001213900-26-101429 | View SEC Doc Filr Page |
| 6-K | 2026-09-18 | 2026-06-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-101419 | View SEC Doc Filr Page |
| EFFECT | 2026-08-26 | — | EFFECT Filing | 9999999995-26-002774 | View SEC Doc Filr Page |
| D | 2026-08-24 | — | D Filing | 0001213900-26-093018 | View SEC Doc Filr Page |
| F-3 | 2026-08-20 | — | REGISTRATION STATEMENT | 0001213900-26-092117 | View SEC Doc Filr Page |
| 6-K | 2026-08-03 | 2026-08-03 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-084652 | View SEC Doc Filr Page |
| 6-K | 2026-07-31 | 2026-07-31 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-083664 | View SEC Doc Filr Page |
| 6-K | 2026-07-15 | 2026-07-15 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-078173 | View SEC Doc Filr Page |
| 6-K | 2026-07-08 | 2026-07-08 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-076199 | View SEC Doc Filr Page |
| 6-K | 2026-07-01 | 2026-07-01 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-074040 | View SEC Doc Filr Page |
| 6-K | 2026-06-30 | 2026-06-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-073725 | View SEC Doc Filr Page |
| EFFECT | 2026-06-17 | — | EFFECT Filing | 9999999995-26-002036 | View SEC Doc Filr Page |
| 6-K | 2026-06-15 | 2026-06-15 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-068524 | View SEC Doc Filr Page |
| F-3/A | 2026-06-10 | — | AMENDMENT NO. 1 TO FORM F-3 | 0001213900-26-067333 | View SEC Doc Filr Page |
| 6-K | 2026-06-05 | 2026-06-05 | CURRENT REPORT | 0001213900-26-065854 | View SEC Doc Filr Page |
| 6-K | 2026-05-27 | 2026-05-27 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-061240 | View SEC Doc Filr Page |
| EFFECT | 2026-05-15 | — | EFFECT Filing | 9999999995-26-001675 | View SEC Doc Filr Page |
| UPLOAD | 2026-05-14 | — | UPLOAD Filing | 0000000000-26-004953 | View SEC Doc Filr Page |
| CORRESP | 2026-05-14 | — | CORRESP Filing | 0001213900-26-056527 | View SEC Doc Filr Page |
| D | 2026-05-13 | — | D Filing | 0001213900-26-055381 | View SEC Doc Filr Page |
| F-3 | 2026-05-11 | — | REGISTRATION STATEMENT | 0001213900-26-054555 | View SEC Doc Filr Page |
| EFFECT | 2026-05-06 | — | EFFECT Filing | 9999999995-26-001512 | View SEC Doc Filr Page |
| POS AM | 2026-05-05 | — | POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1 | 0001213900-26-052205 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-05-04 | — | SCHEDULE 13D Filing | 0001213900-26-051611 | View SEC Doc Filr Page |